Multidimensional Measurement of Psychopharmacological Treatment Response

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

44 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-08-31

Study Completion Date

2011-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study examines actigraphic, observational, psychometric and associated repeated measurements obtained prior to and during psychopharmacological treatment.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Response Variability in Children With Attention Deficit Hyperactivity Disorder (ADHD)

NCT01238822

Attention Deficit Hyperactivity Disorder

COMPLETED PHASE4

Study of Acamprosate in Autism

NCT01813318

Autistic Disorder

COMPLETED PHASE1

Stimulant Versus Nonstimulant Medication for Attention Deficit Hyperactivity Disorder in Children

NCT00183391

Attention Deficit Disorder With Hyperactivity

COMPLETED PHASE4

Development of a Multi-faceted Cognitive Training Program for Children With Attention Deficit Hyperactivity Disorder (ADHD)

NCT01352468

Attention Deficit Hyperactivity Disorder

COMPLETED NA

Acute Effects of Stimulant Medication in College Students With ADHD

NCT03935646

Attention Deficit Hyperactivity Disorder Stimulant Use Working Memory +2 more

RECRUITING PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Baseline actigraphic measurements, multi-symptom operationally defined observations and psychometric data will be established and repeated to measure treatment response. Additional biological and biometric measures that have potential to further characterize the cohorts under study or treatment response will be collected as practical and when possible.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Autism Spectrum Disorders Mood Disorders Sleep Disorders Attention Deficit Disorders

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Autism Spectrum Disorders

This group will include those receiving or anticipating receiving pharmacological intervention whose primary diagnosis is Autism Spectrum Disorder

Pharmacological Intervention

Intervention Type DRUG

This study will include those anticipating or receiving any pharmacological intervention

Attention Deficit Hyperactivity Disorder

This group will include those receiving or anticipating receiving pharmacological intervention whose primary diagnosis is Attention Deficit Hyperactivity Disorder.

Pharmacological Intervention

Intervention Type DRUG

This study will include those anticipating or receiving any pharmacological intervention

Unaffected 1st Degree Relatives

This group will include unaffected, non treated first degree relatives of this study's subjects receiving or anticipating receiving pharmacological intervention.

No interventions assigned to this group

Mood Disorders

This group will include those receiving or anticipating receiving pharmacological intervention whose primary diagnosis is mood disorder.

Pharmacological Intervention

Intervention Type DRUG

This study will include those anticipating or receiving any pharmacological intervention

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Pharmacological Intervention

This study will include those anticipating or receiving any pharmacological intervention

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

antipsychotics antidepressants mood stabilizers stimulants NMDA antagonists

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosis of:
* Autism Spectrum Disorder
* Mood Disorder
* Attention Deficit Hyperactivity Disorder
* Unaffected First Degree Relative of Study Subject
* Anticipation of pharmacological intervention or current pharmacological intervention